Takeda Pharmaceutical (TAK) News Today $14.68 +0.11 (+0.75%) Closing price 05/27/2025 03:59 PM EasternExtended Trading$14.66 -0.02 (-0.14%) As of 05/27/2025 05:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TAK Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Forum Financial Management LP Raises Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)Forum Financial Management LP boosted its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 133.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 114,324 shares of the company's stock afMay 27 at 5:36 AM | marketbeat.comGTS Securities LLC Makes New Investment in Takeda Pharmaceutical Company Limited (NYSE:TAK)GTS Securities LLC bought a new stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 97,558 shares of the company's stock, valued at approximately $1,292,000May 27 at 5:05 AM | marketbeat.com26,600 Shares in Takeda Pharmaceutical Company Limited (NYSE:TAK) Bought by Point72 Asset Management L.P.Point72 Asset Management L.P. bought a new position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm bought 26,600 shares of the company's stock, valued at approximately $352,000. A number of otheMay 26 at 4:07 AM | marketbeat.com510,600 Shares in Takeda Pharmaceutical Company Limited (NYSE:TAK) Acquired by Toronto Dominion BankToronto Dominion Bank purchased a new position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 510,600 shares of the company's stock, valuMay 24, 2025 | marketbeat.comMillennium Management LLC Sells 1,655,703 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Millennium Management LLC cut its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 45.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,000,903 shares of the company's stock after selling 1,655,703 shaMay 22, 2025 | marketbeat.comJanus Henderson Group PLC Has $3.10 Million Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)Janus Henderson Group PLC decreased its position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 8.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 233,950 shares of the coMay 22, 2025 | marketbeat.comSoleus Capital Management L.P. Purchases 680,000 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Soleus Capital Management L.P. raised its position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 136.0% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 1,180,000 shares of the company's stock after acquiring an additMay 21, 2025 | marketbeat.comFocus Partners Wealth Raises Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)Focus Partners Wealth lifted its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 431.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 79,499 shares of the company's stock after acquiMay 20, 2025 | marketbeat.comQuantinno Capital Management LP Increases Stake in Takeda Pharmaceutical Company Limited (NYSE:TAK)Quantinno Capital Management LP raised its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 33.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 48May 19, 2025 | marketbeat.comDimensional Fund Advisors LP Increases Stock Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)Dimensional Fund Advisors LP grew its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 60.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 181,929 shares ofMay 17, 2025 | marketbeat.com230,000 Shares in Takeda Pharmaceutical Company Limited (NYSE:TAK) Purchased by LMR Partners LLPLMR Partners LLP acquired a new stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 230,000 shares of the company's stock, valued at approximately $3,045,000. A nuMay 15, 2025 | marketbeat.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Holdings Raised by Hudson Bay Capital Management LPHudson Bay Capital Management LP lifted its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 10.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 275,000 shares of the company's stock after purchasinMay 15, 2025 | marketbeat.comBalyasny Asset Management L.P. Invests $2.56 Million in Takeda Pharmaceutical Company Limited (NYSE:TAK)Balyasny Asset Management L.P. bought a new position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 193,203 shares of the company's stock, valued at apMay 15, 2025 | marketbeat.comBNP Paribas Financial Markets Has $6.63 Million Stake in Takeda Pharmaceutical Company Limited (NYSE:TAK)BNP Paribas Financial Markets increased its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 15,449.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 500,677 shares of the company's stockMay 15, 2025 | marketbeat.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Stake Increased by Jane Street Group LLCJane Street Group LLC boosted its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 109.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 254,647 shares of the companyMay 15, 2025 | marketbeat.comThe New England Journal of Medicine Publishes Data from Phase 2b Trial of Oral Orexin Receptor 2 Agonist Oveporexton (TAK-861) in People with Narcolepsy Type 1May 14, 2025 | businesswire.comTakeda Pharmaceutical (NYSE:TAK) Shares Gap Down - Should You Sell?Takeda Pharmaceutical (NYSE:TAK) Shares Gap Down - What's Next?May 14, 2025 | marketbeat.comEthic Inc. Sells 113,512 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Ethic Inc. lowered its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 25.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 326,307 shares of the company's stock afteMay 13, 2025 | marketbeat.comNorthern Trust Corp Purchases 238,161 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Northern Trust Corp increased its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 14.6% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,873,588 shares of the company's stock afterMay 13, 2025 | marketbeat.comTrump says he will sign order linking U.S. drug prices to other nations’May 12, 2025 | msn.comTakeda Pharmaceutical (NYSE:TAK) Announces Earnings ResultsTakeda Pharmaceutical (NYSE:TAK - Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.16 earnings per share for the quarter, missing the consensus estimate of $0.24 by ($0.08). The business had revenue of $7.34 billion during the quarter, compared to the consensus estimate of $8.02 billion. Takeda Pharmaceutical had a return on equity of 9.39% and a net margin of 4.53%.May 12, 2025 | marketbeat.comPharmaceutical Stocks Tumble as Trump Plans US Drug Price CutsMay 12, 2025 | msn.comPharmaceutical Stocks Tumble on Trump Plan to Cut US Drug PricesMay 12, 2025 | finance.yahoo.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Shares Sold by Ellevest Inc.Ellevest Inc. lowered its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 48.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 40,379 shares of the company's stock after selling 38,549 shares during theMay 12, 2025 | marketbeat.comTrump Seeks to Align US Drug Costs With Cheapest Ones AbroadMay 11, 2025 | msn.comTakeda Pharmaceuticals Caps A Strong Year, Guidance Suggests Dividend Is On The RiseMay 11, 2025 | seekingalpha.comCubist Systematic Strategies LLC Acquires New Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)Cubist Systematic Strategies LLC bought a new position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 446,764 shares of the company's stock, valued at approxMay 11, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Has $865,000 Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)Schonfeld Strategic Advisors LLC lowered its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 21.5% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 65,351 shares of the company's stock after selling 17,851 shares duringMay 11, 2025 | marketbeat.comTakeda Pharmaceutical (NYSE:TAK) Updates FY 2025 Earnings GuidanceTakeda Pharmaceutical (NYSE:TAK) updated its FY 2025 earnings guidance. The company provided EPS guidance of 3.180-3.180 for the period.May 10, 2025 | marketbeat.comH-E-B and other retailers go after big pharma in new lawsuitsMay 9, 2025 | msn.comTakeda Pharmaceutical Company Limited (TAK) Q4 2024 Earnings Call TranscriptMay 9, 2025 | seekingalpha.comTakeda Pharmaceutical FY Oper Pft Y342.59B Vs Pft Y214.08BMay 8, 2025 | marketwatch.comJapanese Pharma Company Takeda Expects Limited Exposure To US-China TariffsMay 8, 2025 | benzinga.comTakeda Pharmaceutical (NYSE:TAK) Hits New 52-Week High - Still a Buy?Takeda Pharmaceutical (NYSE:TAK) Hits New 12-Month High - Time to Buy?May 8, 2025 | marketbeat.comLido Advisors LLC Invests $364,000 in Takeda Pharmaceutical Company Limited (NYSE:TAK)Lido Advisors LLC purchased a new stake in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 27,487 shares of theMay 8, 2025 | marketbeat.comTakeda Announces FY2024 Full Year Results and FY2025 Outlook Reflecting Growth & Launch Products Momentum, Strong Cash Flow Generation and Late-Stage Pipeline ProgressMay 8, 2025 | businesswire.comH-E-B, other retailers accuse pharmaceutical companies of having monopoliesMay 7, 2025 | msn.comTakeda Pharmaceutical Expected to Post Fourth-Quarter Net Loss -- Earnings PreviewMay 7, 2025 | marketwatch.comNovavax, Inc.: Novavax Announces Significantly Improved Terms for Collaboration and License Agreement with Takeda for Nuvaxovid in JapanMay 5, 2025 | finanznachrichten.deNovavax Announces Improved Financial Terms In Its Agreement With Takeda For Nuvaxovid In JapanMay 5, 2025 | finanznachrichten.deTakeda Pharmaceutical Company Limited (NYSE:TAK) Stock Position Lifted by Tower Research Capital LLC TRCTower Research Capital LLC TRC lifted its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 413.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 20May 5, 2025 | marketbeat.comRaymond James Financial Inc. Purchases New Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)Raymond James Financial Inc. acquired a new position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 109,317 shares of the cMay 5, 2025 | marketbeat.comMarshall Wace LLP Buys Shares of 76,254 Takeda Pharmaceutical Company Limited (NYSE:TAK)Marshall Wace LLP purchased a new position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 76,254 shares of the company's stock, valued at approximately $1,010,000. A number of other lMay 3, 2025 | marketbeat.comAquatic Capital Management LLC Buys 61,927 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)Aquatic Capital Management LLC increased its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 52.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 180,927 shares of the company's stocMay 1, 2025 | marketbeat.comTakeda Awards $13.8 Million to U.S. Nonprofit Partners to Promote Healthy Eating and Expand ...April 30, 2025 | gurufocus.comTakeda Awards $13.8 Million to U.S. Nonprofit Partners to Promote Healthy Eating and Expand STEM EducationApril 30, 2025 | businesswire.comJPMorgan Chase & Co. Has $1.11 Million Stock Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)JPMorgan Chase & Co. boosted its holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 94.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 83,826 shares of the company's stock after purchasiApril 29, 2025 | marketbeat.comSyon Capital LLC Has $486,000 Stake in Takeda Pharmaceutical Company Limited (NYSE:TAK)Syon Capital LLC lowered its position in Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 41.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 36,680 shares of the company's stock after selling 25,626 shares during the period. SApril 27, 2025 | marketbeat.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Shares Acquired by Mariner LLCMariner LLC raised its position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 14.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 142,504 shares of the company's stock after purchasing anApril 27, 2025 | marketbeat.comTakeda Pharmaceutical Company Limited (NYSE:TAK) Shares Purchased by First Trust Advisors LPFirst Trust Advisors LP boosted its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 2.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,240,932 shares of the company's stock afteApril 26, 2025 | marketbeat.com Get Takeda Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter. Email Address TAK Media Mentions By Week TAK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TAK News Sentiment▼1.241.03▲Average Medical News Sentiment TAK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TAK Articles This Week▼75▲TAK Articles Average Week Get Takeda Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for TAK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SNY News Today GSK News Today ARGX News Today ONC News Today BNTX News Today TEVA News Today SMMT News Today ITCI News Today GMAB News Today RDY News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:TAK) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Takeda Pharmaceutical Company Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Takeda Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TAK Stock Free TAK Stock Alerts